Learn More CSL Ltd (ASX: CSL) shares have lifted more than 2% into the green this past month of trade, outpacing the broader market in that time. The biotech giant held its annual general meeting ...

(RTTNews) - At the Annual General Meeting, Paul McKenzie, Chief Executive Officer of CSL Ltd. (CSL.AX), reaffirmed the company's financial guidance for fiscal year 2025. The company still expects ...

Shares of building envelope solutions provider Carlisle Companies (NYSE:CSL) fell 8.4% in the morning session after the company reported disappointing third-quarter earnings results. Its revenue ...

In a report released yesterday, Steven Wheen from Jarden maintained a Buy rating on CSL (CMXHF – Research Report), with a price target of A$329.62. The company’s shares closed today at $191.55.

Building envelope solutions provider Carlisle Companies (NYSE:CSL) fell short of the market’s revenue expectations in Q3 CY2024, but sales rose 5.9% year on year to $1.33 billion. Its non-GAAP ...

The partnership will enhance the country’s capacity to explore and develop its offshore resources, bringing with it significant benefits for PNG’s economy and the industry. Mr Maladina signed the ...

The $1.25 million CSL Centenary Fellowship has enabled Dr Weeden to return from the Crick Institute in London to establish her own research laboratory at WEHI in Melbourne. She plans to identify how ...

A rumor that food company Land O'Lakes had announced a return to its previous logo featuring a kneeling Indigenous woman on its packaging circulated online in October 2024. A Facebook post ...

CSL (AU:CSL) has released an update. CSL Limited is hosting its 2024 Research & Development Investor Briefing, offering investors insights into the company’s latest innovations and strategic ...

Explore the YouTube logo design, uncover psychology, and learn tips for creating unforgettable logos. Elevate your brand with expert insights. Have you ever caught yourself mindlessly scrolling ...

Bell Potter highlights that there is a lot to like about CSL. It notes that the company holds the number one and number two positions in its three key markets. These are plasma-derived therapies ...